Mohammed Alhammouri, MD
Critical Care Medicine · Glendale, AZNPI 1649219270
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Abbott at 21.2% of the total. Reporting peaked in 2023 at $388 and has fallen 87.3% since, to $49 in 2024.
Across 7 payments — averaging $100.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$148
- Abiomed$137
- Baxter Healthcare$125
- Takeda Pharmaceuticals U.S.A., Inc.$116
- ZOLL Circulation Inc$103
- Penumbra, Inc.$49
- plus $22 from 1 others
What the payments were for
- Food & beverage$700100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 1 | $148 |
| Abiomed | 1 | $137 |
| Baxter Healthcare | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $116 |
| ZOLL Circulation Inc | 1 | $103 |
| Penumbra, Inc. | 1 | $49 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DRAGONFLY OPSTAR$148
- Impella$137
- GLASSIA$116
- TherOx DS2 Console$103
- Catheter$103
- Downstream Cartridge$103
How this compares
$700 in reported general payments places this provider in the 60th percentile of 175 critical care medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Glendale
- Naomi HabibPhoenix$298K
- Heather PrzybylPhoenix$126K
- Douglas MapelPrescott$125K
- Akshay MuralidharScottsdale$44K
- Syed ShahryarPhoenix$20K
- Rodrigo Cartin-CebaScottsdale$18K
- Robert MathenyKingman$10K
- Reena BansalScottsdale$10K
- Lina AnthonyMesa$6K
- Blythe DemelloTucson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.